The Braves’ winter full of arbitration cases was an indication of the problems lurking just beyond the horizon — their core of young, talented players is starting to get very expensive, and inching ever closer to free agency. The organization has been among the more thrifty in Major League Baseball lately, keeping a payroll below $100 million in each of the last five seasons. As Mark Bradley of the Atlanta Journal Constitution writes, it will be tough for the Braves to lock up their core players. Brian McCann received the Braves’ last contract extension: a six-year, $26.8 million extension signed in March 2007.
The Braves had 14 arbitration eligible players this off-season. They tendered contracts to 11 of them:
- SP Kris Medlen, $5.8 million (second year of arbitration eligibility)
- 3B Chris Johnson, $4.75 million (first year)
- SP Mike Minor, $3.85 million (first year)
- RP Jonny Venters, $1.625 million (second year)
- RP Jordan Walden, $1.49 million (first year)
- SP Brandon Beachy, $1.45 million (first year)
- OF Jordan Schafer, $1.09 million (first year)
- IF Ramiro Pena, $0.55 million (first year)
They will go to arbitration hearings with outfielder Jason Heyward (second year of arbitration eligibility), first baseman Freddie Freeman (first year), and closer Craig Kimbrel (first year). The midpoint between the salary figures submitted by the Braves and both Freeman and Heyward is around $5 million, while it’s around $7 million for Kimbrel.
The more Sabermetrically-inclined in the Braves blogosphere have suggested that the Braves should trade Kimbrel, so that would be one solution to one dilemma. Locking up Heyward, Freeman, Medlen, Minor, and Beachy will be trickier. The longer the Braves wait, the more expensive their core becomes and the more likely it becomes that they will watch their key players eventually walk away into free agency. The Braves are among the best in the business at recognizing and developing talent, but even they can’t count on consistently churning out Freemans, Minors, and Heywards to replace outgoing talent.
According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.
A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.
Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.
Espinosa will reach free agency after the 2017 season.
The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.
The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.
Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.
Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.